Through bioactivity-guided fractionation, eight phorbol diesters, including five new ones (1-5), were isolated from the seeds of Croton tiglium collected in Egypt. 12-O-Acetylphorbol-13-decanoate (6) and 12-O-decanoylphorbol-13-(2-methylbutyrate) (4) potently inhibited the HIV-1-induced cytopathic effect on MT-4 cells (IC 100 values of 7.6 ng/ml and 7.81 m mg/ml, and CC 0 values of 62.5 m mg/ml and 31.3 m mg/ml, respectively) without activating protein kinase C.
Although phorbol esters elicit a wide range of biochemical effects, 1 ,2) a prevailing concern is their possible tumor-promoting effects. Different experiments indicated that tumorpromoting phorbol esters interact with and activate protein kinase C (PKC).
3,4) It has been reported that the PKC family plays an important role in signal transduction in normal cells and its elevated activation has been detected in several cancer cell lines. Chowdhury et al. 4) found that the tumor-promoting and the HIV-1 inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) were mediated through its direct activation of PKC. However, there are many phorbol esters that are biologically active without being tumor-promoters. 12-OTigloylphorbol-13-decanoate, 5) ostodin, and 12-O-undecadienoylphorbol-13-acetate, 6) are potent antitumor agents. Prostratin, 12-deoxyphorbol-13-acetate, is a potent anti-HIV-1 agent without tumor-promoting action. 7) We previously reported that extracts of the seeds of Croton tiglium L. collected in Egypt significantly inhibited HIV-1.
8) Therefore extracts of this plant were investigated to isolate a selective inhibitor of HIV-1 that does not activate PKC. From the MeOH extract, we have now isolated 8 phorbol diesters (Chart 1). Compounds 1-5 are new 9) and 6-8 were known compounds. 10, 11) The structures of these compounds were established by 2D-NMR spectroscopy ( 1 H-1 H COSY, HMQC, HMBC, and NOESY) and selective hydrolysis of acyl groups followed by GC/MS. The details of the structure elucidation will be reported elsewhere. Table 1 shows the inhibitory activity of 1-8 against the cytopathic effects (CPE) of HIV-1 in MT-4 cells, 12) and their activation of PKC. The 13,20-diesters, 1 and 2, demonstrated complete inhibition of CPE at concentrations (IC 100 ) of 15.6 mg/ml and 7.81 mg/ml, with minimum cytotoxic concentrations (CC 0 ) of 62.5 mg/ml for both. However, phorbol 12,13-diesters contained long-chain and short-chain acyl groups (long-chain at C-12 as in 8, or at C-13 as in 6) and demonstrated potent inhibition of HIV-1-induced CPE at very low 12) using HTLV-I-carrying cell line MT-4. b) Assayed by measuring the incorporation of 32 P radioactivity from [g-32 P]ATP into a peptide, Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH, using a Biotrak PKC enzyme assay system code RPN 77 kit except that the TPA in the kit was replaced by 1-8 (2.7 mg/ml and 10 ng/ml) in DMSO at a final concentration of 0.02%. c) IC 100 : the minimal concentration for complete inhibition of HIV-1-induced CPE in MT-4 cells, determined by microscopic observation. d) CC 0 : the minimal concentration for the appearance of MT-4 cell toxicity, determined by microscopic observation. * Activation of PKC was not observed at 100 ng/ml. DS 8000: Dextrine sulfate.
Chart 1 concentrations of 0.00048 mg/ml and 0.0076 mg/ml, respectively. Compound 4, with C 10 and C 5 acyl groups, completely inhibited HIV-1 at 7.81 mg/ml, while 7, with C 5 and C 12 , demonstrated the same inhibitory potency as that of 1. Phorbol diesters containing two short acyl residues (3 and 5) showed no appreciable anti-HIV CPE activity. These compounds were tested for their abilities to activate PKC by measuring the incorporation of 32 P from [g-
32
P]ATP into a peptide. It was found that TPA (8), the most potent tumor promoter known so far, activated PKC by almost 100% at a concentration of 10 ng/ml. However, 6, which demonstrated potent anti-HIV-1 effects, showed no activation of PKC at concentrations of 10-100 ng/ml. Compounds 1 and 4 did not activate PKC at 10 ng/ml, while 2, 3, 5, and 7 demonstrated 10-16% increases in the activity of PKC. Although the experimental conditions were not identical to ours, prostratin (potent anti-HIV-1 12-deoxyphorbol-13-acetate) was reported to show an IC 100 Ն1 mM (0.39 mg/ml) and weak PKC activation.
7) Compound 4 was also a selective inhibitor of HIV-1, and the very potent effects of 6 led us to assume that the effects of phorbol esters were influenced by chain length and acyl group position. This observation encouraged us to carry out further modification of these compounds to clarify the structural features required for their selective anti-HIV-1 effects. The results of this study will be reported in a forthcoming paper. T., El-Mekkawy S., Hattori M., Namba T., J. Trad. Med., 13, 59-65 (1996). 9) Compound 1 (13-O-acetylphorbol-20-linoleate): an oily substance, [a] 
